Literature DB >> 24123001

Radiation-induced dimer formation of EGFR: implications for the radiosensitizing effect of cetuximab.

Makoto Kiyozuka1, Tetsuo Akimoto, Mika Fukutome, Atsushi Motegi, Norio Mitsuhashi.   

Abstract

AIM: The purpose of this study was to investigate whether radiation induces ligand-independent dimerization of epidermal growth factor receptor (EGFR) and explore the possible role of radiation-induced receptor dimerization in the radiosensitizing effect of cetuximab.
MATERIALS AND METHODS: The human vulvar squamous cell carcinoma cell line A431 was used. The dimerization and activation of EGFR were quantified using immunoprecipitation, a western blotting analysis, and a chemical cross-linking analysis with dithiobis-sulfosuccinimidyl propionate.
RESULTS: Irradiation at a dose of 2 Gy induced the autophosphorylation of EGFR. Consistent with autophosphorylation, a 360-kDa polypeptide, corresponding to the size of the EGFR dimer, was detected in addition to an EGFR monomer. Radiation also induced hetero-dimerization between EGFR and HER2/neu. Cetuximab combined with radiation inhibited radiation-induced autophosphorylation of EGFR, and inhibited radiation-induced homo-dimerization of EGFR. However, cetuximab incompletely inhibited radiation-induced hetero-dimerization between EGFR and HER2.
CONCLUSION: The results of this investigation suggest that radiation-induced homo- and/or hetero-dimerization between EGFR and/or HER2 might be involved in the radioresponse of cancer cells.

Entities:  

Keywords:  A431 cells; EGFR; cetuximab; dimerization; radiation; radiosensitivity

Mesh:

Substances:

Year:  2013        PMID: 24123001

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Evaluation of a Small Animal Irradiation System for Animal Experiments Using EBT3 Model GAFCHROMIC™ Film.

Authors:  Yasuyuki Shimizu; Hiroaki Akasaka; Daisuke Miyawaki; Naritoshi Mukumoto; Masao Nakayama; Tianyuan Wang; Saki Osuga; Sachiko Inubushi; Ryuichi Yada; Yasuo Ejima; Kenji Yoshida; Takeaki Ishihara; Ryohei Sasaki
Journal:  Kobe J Med Sci       Date:  2018-01-17

2.  A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation.

Authors:  Y Yan; A L Hein; P M Greer; Z Wang; R H Kolb; S K Batra; K H Cowan
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

Review 3.  Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies.

Authors:  Salma K Jabbour; Terence M Williams; Mutlay Sayan; Eric D Miller; Jaffer A Ajani; Andrew C Chang; Norman Coleman; Wael El-Rifai; Michael Haddock; David Ilson; Daniel Jamorabo; Charles Kunos; Steven Lin; Geoffrey Liu; Pataje G Prasanna; Anil K Rustgi; Rosemary Wong; Bhadrasain Vikram; Mansoor M Ahmed
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

4.  The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

Authors:  Oana Alexandru; Stefana Oana Purcaru; Ligia Gabriela Tataranu; Laura Lucan; Juan Castro; Catalin Folcuţi; Stefan-Alexandru Artene; Cristian Tuţă; Anica Dricu
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

5.  Quantitative Tyrosine Phosphoproteomic Analysis of Resistance to Radiotherapy in Nasopharyngeal Carcinoma Cells.

Authors:  Lin Shen; Zhanzhan Li; Liangfang Shen
Journal:  Cancer Manag Res       Date:  2020-12-09       Impact factor: 3.989

Review 6.  Radiation-induced signaling pathways that promote cancer cell survival (review).

Authors:  Ashley L Hein; Michel M Ouellette; Ying Yan
Journal:  Int J Oncol       Date:  2014-08-20       Impact factor: 5.650

Review 7.  Cell Signaling Pathways That Promote Radioresistance of Cancer Cells.

Authors:  Michel M Ouellette; Sumin Zhou; Ying Yan
Journal:  Diagnostics (Basel)       Date:  2022-03-08

8.  Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.

Authors:  Raik Schneider; Günther Gademann; Hans-Joachim Ochel; Karsten Neumann; Burkhard Jandrig; Peter Hass; Mathias Walke; Martin Schostak; Thomas Brunner; Frank Christoph
Journal:  Radiat Oncol       Date:  2021-07-28       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.